This report describes and explains the high potency APIs market and covers 2016-2021, termed the historic period, and 2021-2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
The global high potency APIs market reached a value of nearly $19,772.2 million in 2021, having grown at a compound annual growth rate (CAGR) of 5.2% since 2016. The market is expected to grow from $19,772.2 million in 2021 to $30,405.1 million in 2026 at a rate of 9.0%. The market is then expected to grow at a CAGR of 9.5% from 2026 and reach $47,914.6 million in 2031.
Growth in the historic period resulted from increasing demand for oncology therapies, rising emphasis of pharmaceutical companies on manufacturing of HPAPIs, a rise in healthcare awareness and expenditure, strong economic growth in emerging markets and increasing government initiatives. Factors that negatively affected growth in the historic period were challenges due to regulatory changes and high costs of drug approval.
Going forward, a rise in the number of cancer cases, growing focus on precision medicine and increasing ageing population will drive the growth. Factors that could hinder the growth of the high potency APIs market in the future include rising popularity of alternative therapies and natural remedies and high manufacturing costs.
The high potency APIs market is segmented by type into innovative HPAPI and generic HPAPI. The innovative HPAPI market was the largest segment of the high potency APIs market segmented by type, accounting for 73.9% of the total in 2021. Going forward, the innovative HPAPI segment is expected to be the fastest growing segment in the high potency APIs market segmented by type, at a CAGR of 9.4% during 2021-2026.
The high potency APIs market is also segmented by synthesis type into synthetic HPAPI and biotech HPAPI. The synthetic HPAPI market was the largest segment of the high potency APIs market segmented by synthesis type, accounting for 77.2% of the total in 2021. Going forward, the biotech HPAPI segment is expected to be the fastest growing segment in the high potency APIs market segmented by synthesis type, at a CAGR of 9.7% during 2021-2026.
The high potency APIs market is also segmented by therapeutic application into oncology, hormonal disorder, glaucoma and other therapeutic applications. The oncology market was the largest segment of the high potency APIs market segmented by therapeutic application, accounting for 43.2% of the total in 2021. Going forward, the glaucoma segment is expected to be the fastest growing segment in the high potency APIs market segmented by therapeutic application, at a CAGR of 9.9% during 2021-2026.
North America was the largest region in the high potency APIs market, accounting for 36.6% of the total in 2021. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the high potency APIs market will be Asia Pacific and North America where growth will be at CAGRs of 9.8% and 9.5% respectively. These will be followed by Western Europe and South America where the markets are expected to grow at CAGRs of 8.4% and 7.0% respectively.
The global high potency APIs market is fragmented, with a large number of small players. The top ten competitors in the market made up to 9.12% of the total market in 2021. This can be due to the existence of number of local players in the market serving customers in particular geographies. Merck KGaA was the largest competitor with 2.68% share of the market, followed by Pfizer, Inc with 1.31%, Thermo Fisher Scientific, Inc with 1.13%, Teva Pharmaceuticals with 1.05%, Lonza Group AG with 0.80%, Sanofi (EUROAPI) with 0.62%, Corden Pharma International with 0.54%, Dr. Reddy’s Laboratories Ltd. with 0.43%, Siegfried Holding AG with 0.35%, and Novartis with 0.21%.
The top opportunities in the high potency APIs market segmented by type will arise in the innovative HPAPI segment, which will gain $8,262.5 million of global annual sales by 2026. The top opportunities in the high potency APIs market segmented by synthesis type will arise in the synthetic HPAPI segment, which will gain $7,980.4 million of global annual sales by 2026. The top opportunities in the high potency APIs market segmented by therapeutic application will arise in the oncology segment, which will gain $4,085.8 million of global annual sales by 2026. The high potency APIs market size will gain the most in the USA at $4,074.7 million.
Market-trend-based strategies for the high potency APIs market include focus on strategies such as production facility expansion and mergers and acquisitions, focus on increasing investments to grow HPAPI production, use of artificial intelligence (AI) in manufacturing APIs, focus on green manufacturing and focus on launch of new, innovative products.
Player-adopted strategies for the high potency APIs market include focus on strategic investments to expand operations, focus on new product approvals and focus on improving production capabilities through strategic investments.
To take advantage of the opportunities, the publisher recommends the HP (high potency) APIs companies to use artificial intelligence (AI), focus on green manufacturing, launch new, innovative products, expand in emerging markets, scale up through merger and acquisition activity, provide competitively priced offerings, continue to participate in events and conferences, focus on fast-growing therapeutic applications and focus on securing long-term supply contracts with pharmaceutical companies.
The global high potency APIs market reached a value of nearly $19,772.2 million in 2021, having grown at a compound annual growth rate (CAGR) of 5.2% since 2016. The market is expected to grow from $19,772.2 million in 2021 to $30,405.1 million in 2026 at a rate of 9.0%. The market is then expected to grow at a CAGR of 9.5% from 2026 and reach $47,914.6 million in 2031.
Growth in the historic period resulted from increasing demand for oncology therapies, rising emphasis of pharmaceutical companies on manufacturing of HPAPIs, a rise in healthcare awareness and expenditure, strong economic growth in emerging markets and increasing government initiatives. Factors that negatively affected growth in the historic period were challenges due to regulatory changes and high costs of drug approval.
Going forward, a rise in the number of cancer cases, growing focus on precision medicine and increasing ageing population will drive the growth. Factors that could hinder the growth of the high potency APIs market in the future include rising popularity of alternative therapies and natural remedies and high manufacturing costs.
The high potency APIs market is segmented by type into innovative HPAPI and generic HPAPI. The innovative HPAPI market was the largest segment of the high potency APIs market segmented by type, accounting for 73.9% of the total in 2021. Going forward, the innovative HPAPI segment is expected to be the fastest growing segment in the high potency APIs market segmented by type, at a CAGR of 9.4% during 2021-2026.
The high potency APIs market is also segmented by synthesis type into synthetic HPAPI and biotech HPAPI. The synthetic HPAPI market was the largest segment of the high potency APIs market segmented by synthesis type, accounting for 77.2% of the total in 2021. Going forward, the biotech HPAPI segment is expected to be the fastest growing segment in the high potency APIs market segmented by synthesis type, at a CAGR of 9.7% during 2021-2026.
The high potency APIs market is also segmented by therapeutic application into oncology, hormonal disorder, glaucoma and other therapeutic applications. The oncology market was the largest segment of the high potency APIs market segmented by therapeutic application, accounting for 43.2% of the total in 2021. Going forward, the glaucoma segment is expected to be the fastest growing segment in the high potency APIs market segmented by therapeutic application, at a CAGR of 9.9% during 2021-2026.
North America was the largest region in the high potency APIs market, accounting for 36.6% of the total in 2021. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the high potency APIs market will be Asia Pacific and North America where growth will be at CAGRs of 9.8% and 9.5% respectively. These will be followed by Western Europe and South America where the markets are expected to grow at CAGRs of 8.4% and 7.0% respectively.
The global high potency APIs market is fragmented, with a large number of small players. The top ten competitors in the market made up to 9.12% of the total market in 2021. This can be due to the existence of number of local players in the market serving customers in particular geographies. Merck KGaA was the largest competitor with 2.68% share of the market, followed by Pfizer, Inc with 1.31%, Thermo Fisher Scientific, Inc with 1.13%, Teva Pharmaceuticals with 1.05%, Lonza Group AG with 0.80%, Sanofi (EUROAPI) with 0.62%, Corden Pharma International with 0.54%, Dr. Reddy’s Laboratories Ltd. with 0.43%, Siegfried Holding AG with 0.35%, and Novartis with 0.21%.
The top opportunities in the high potency APIs market segmented by type will arise in the innovative HPAPI segment, which will gain $8,262.5 million of global annual sales by 2026. The top opportunities in the high potency APIs market segmented by synthesis type will arise in the synthetic HPAPI segment, which will gain $7,980.4 million of global annual sales by 2026. The top opportunities in the high potency APIs market segmented by therapeutic application will arise in the oncology segment, which will gain $4,085.8 million of global annual sales by 2026. The high potency APIs market size will gain the most in the USA at $4,074.7 million.
Market-trend-based strategies for the high potency APIs market include focus on strategies such as production facility expansion and mergers and acquisitions, focus on increasing investments to grow HPAPI production, use of artificial intelligence (AI) in manufacturing APIs, focus on green manufacturing and focus on launch of new, innovative products.
Player-adopted strategies for the high potency APIs market include focus on strategic investments to expand operations, focus on new product approvals and focus on improving production capabilities through strategic investments.
To take advantage of the opportunities, the publisher recommends the HP (high potency) APIs companies to use artificial intelligence (AI), focus on green manufacturing, launch new, innovative products, expand in emerging markets, scale up through merger and acquisition activity, provide competitively priced offerings, continue to participate in events and conferences, focus on fast-growing therapeutic applications and focus on securing long-term supply contracts with pharmaceutical companies.
Table of Contents
1. High Potency APIs Market Executive Summary2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. High Potency APIs Market Definition and Segmentations
6.4. Market Segmentation By Type
6.4.1. Innovative HPAPI
6.4.2. Generic HPAPI
6.5. Market Segmentation By Synthesis Type
6.5.1. Synthetic HPAPI
6.5.2. Biotech HPAPI
6.6. Market Segmentation By Therapeutic Application
6.6.1. Oncology
6.6.2. Hormonal Disorder
6.6.3. Glaucoma
6.6.4. Other Therapeutic Applications
7. Major Market Trends
7.1. Focus On Production Facility Expansion And Mergers & Acquisitions
7.2. Increasing Investment
7.3. Use Of Artificial Intelligence (AI)
7.4. Greener API Manufacturing
7.5. Launch Of New Products
8. Global Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
8.2.1. Market Drivers 2016 - 2021
8.2.2. Market Restraints 2016 - 2021
8.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
8.3.1. Market Drivers 2021 - 20268.3.2. Market Restraints 2021 - 2026
9. High Potency APIs Market, Regional Analysis
9.1. Global High Potency APIs Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.2. Global High Potency APIs Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10. Global High Potency APIs Market Segmentation
10.1. Global High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10.2. Global High Potency APIs Market, Segmentation By Synthesis Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10.3. Global High Potency APIs Market, Segmentation By Therapeutic Applications, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.4. Asia-Pacific High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.5. Asia-Pacific High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.6. Asia Pacific High Potency APIs Market: Country Analysis
11.7. China Market
11.8. Summary
11.9. Market Overview
11.9.1. Region Information
11.9.2. Market Information
11.9.3. Background Information
11.9.4. Government Initiatives
11.9.5. Regulations
11.9.6. Regulatory Bodies
11.9.7. Major Associations
11.9.8. Taxes Levied
11.9.9. Corporate Tax Structure
11.9.10. Investments
11.9.11. Major Companies
11.10. China High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.11. China High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.12. China High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.13. India Market
11.14. India High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.15. India High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.16. India High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.17. Japan Market
11.18. Japan High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.19. Japan High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.20. Japan High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.21. Australia Market
11.22. Australia High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.23. Australia High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.24. Australia High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.25. Indonesia Market
11.26. Indonesia High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.27. Indonesia High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.28. Indonesia High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.29. South Korea Market
11.30. South Korea High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.31. South Korea High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.32. South Korea High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.4. Western Europe High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.5. Western Europe High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe High Potency APIs Market: Country Analysis
12.7. UK Market
12.8. UK High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.9. UK High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.10. UK High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.11. Germany Market
12.12. Germany High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.13. Germany High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.14. Germany High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.15. France Market
12.16. France High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.17. France High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.18. France High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.4. Eastern Europe High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.5. Eastern Europe High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe High Potency APIs Market: Country Analysis
13.7. Russia Market
13.8. Russia High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.9. Russia High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.10. Russia High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America High Potency APIS Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.4. North America High Potency APIS Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.5. North America High Potency APIS Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.6. North America High Potency APIs Market: Country Analysis
14.7. USA Market
14.8. Summary
14.9. Market Overview
14.9.1. Country Information
14.9.2. Market Information
14.9.3. Background Information
14.9.4. Government Initiatives
14.9.5. Regulations
14.9.6. Regulatory Bodies
14.9.7. Major Associations
14.9.8. Taxes Levied
14.9.9. Corporate Tax Structure
14.9.10. Investments
14.9.11. Major Companies
14.10. USA High Potency APIS Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.11. USA High Potency APIS Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.12. USA High Potency APIS Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America High Potency APIS Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.4. South America High Potency APIS Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.5. South America High Potency APIS Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. South America High Potency APIS Market: Country Analysis
15.7. Brazil Market
15.8. Brazil High Potency APIS Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.9. Brazil High Potency APIS Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.10. Brazil High Potency APIS Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East High Potency APIS Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.4. Middle East High Potency APIS Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.5. Middle East High Potency APIS Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa High Potency APIs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.4. Africa High Potency APIs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.5. Africa High Potency APIs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18. Pipeline Analysis
19. Competitive Landscape And Company Profiles
19.1. Merck KGaA
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Business Strategy
19.1.4. Financial Overview
19.2. Pfizer Inc Company
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial overview
19.3. Thermo Fisher Scientific Inc
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
19.4. Teva Pharmaceuticals
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Financial Overview
19.5. Lonza Group AG
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Business Strategy
19.5.4. Financial Overview
20. Key Mergers and Acquisitions In The Market
20.1. Pfizer Acquired Arena Pharmaceuticals
20.2. Permira Funds Acquired Cambrex Corporation
20.3. Bristol-Myers Squibb Acquired Celgene Corporation
20.4. Takeda Pharmaceutical Company Limited Acquired Shire Plc
20.5. Novartis acquired GSK’s Cephalosporin
21. Global High Potency APIs Market Opportunities And Strategies
21.1. Global High Potency APIs Market In 2026 - Countries Offering Most New Opportunities
21.2. Global High Potency APIs Market In 2026 - Segments Offering Most New Opportunities
21.3. Global High Potency APIs Market In 2026 - Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. HP (High Potency) APIs Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. About the Publisher23.5. Copyright and Disclaimer
Executive Summary
High Potency APIs Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global high potency APIs market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:
Where is the largest and fastest growing market for high potency APIs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The high potency APIs market global report answers all these questions and many more.The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider high potency APIs market; and compares it with other markets.
The report covers the following chapters
- Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the high potency APIs market.
- Key Trends - Highlights the major trends shaping the global high potency APIs market. This section also highlights likely future developments in the market.
- Global Market Size And Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region.
- Market Segmentation - Contains the market values (2016-2031) and analysis for for segment by type, by synthesis type and by therapeutic application in the market.
- Regional Market Size And Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Pipeline Analysis - Briefs on the pipeline analysis of high potency APIs from the major players in the market.
- Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations - Includes recommendations for high potency APIs providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered:
1) By Type: Innovative HPAPI; Generic HPAPI2) By Synthesis Type: Synthetic HPAPI; Biotech HPAPI
3) By Therapeutic Application: Oncology; Hormonal Disorder; Glaucoma; Other Therapeutic Applications
Companies Mentioned: Merck KGaA; Pfizer, Inc; Thermo Fisher Scientific, Inc; Teva Pharmaceuticals; Lonza Group AG
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; high potency APIs indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Merck KGaA
- Pfizer, Inc.
- Thermo Fisher Scientific, Inc.
- Teva Pharmaceuticals
- Lonza Group AG
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 230 |
| Published | July 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 19772.2 Million |
| Forecasted Market Value ( USD | $ 47914.6 Million |
| Compound Annual Growth Rate | 9.3% |
| Regions Covered | Global |
